Ledger.Open graph →
SEC Form D · filed March 27, 2018

Unity Biotechnology, Inc

Offering
$60.0M
Sold
$55.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BRISBANE, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Keith E. Leonard · Brisbane, CAExec · DirectorCamille E. Samuels · Brisbane, CADirectorDan E. Marquess · Brisbane, CAExecNathaniel E. David · Brisbane, CAExec · DirectorKristina E. Burow · Brisbane, CADirectorJamie E. Dananberg · Brisbane, CAExecRobert E. Nelsen · Brisbane, CADirectorGraham E. Cooper · Brisbane, CADirectorJerry S. Lanchbury · Salt Lake City, UTExec · DirectorAndreas M. Weiskam · Palo Alto, CADirectorMark C. Capone · Salt Lake ity, UTExecNino N. Marakovic · Palo Alto, CAExec · DirectorDavid A. Hartwig · Palo Alto, CAExecJason Jaeger · Santa Barbara, CADirectorRichard D. Higgins · Palo Alto, CADirectorJayendra N. Das · Palo Alto, CADirectorTamara E. Tompkins · Brisbane, CAExecPaul E. Berns · Brisbane, CADirectorBob E. Goeltz · Brisbane, CAExecTatyana A. Gubin · Allston, MAExec · DirectorBritta Perkio · Charlotte, NCExecBrigid Breen · Charlotte, NCDirectorAlan Joslyn · Tampa, FLDirectorStephen Bloch · Westport, CTExec · DirectorAudrey Martin · New York, NYExecMark Hargrove · New York, NYDirectorScott B. Burell · HINGHAM, MADirectorTamara E. Tompkins · Brisbane, CAExecPaul E. Berns · Brisbane, CADirectorBob E. Goeltz · Brisbane, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗